[HTML][HTML] Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer
Simple Summary In patients with differentiated thyroid cancer (DTC), the American Thyroid
Association dynamic risk stratification system has been proposed to identify patients at …
Association dynamic risk stratification system has been proposed to identify patients at …
Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer
S Ito, S Iwano, K Kato, S Naganawa - Annals of Nuclear Medicine, 2018 - Springer
Objective To identify prognostic factors associated with a low-iodine diet (LID) and the
amount of remnant thyroid tissue in Japanese patients with differentiated thyroid cancer …
amount of remnant thyroid tissue in Japanese patients with differentiated thyroid cancer …
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
FA Verburg, RBT Verkooijen… - Nuklearmedizin …, 2009 - thieme-connect.com
Objective: Dosimetry studies have shown that activities of 131 I as small as 10-20 MBq may
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …
cause a stunning effect. A result of this stunning effect may be a lower success rate of the …
Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low‐risk well‐differentiated thyroid cancer
S Tsirona, V Vlassopoulou, M Tzanela… - Clinical …, 2014 - Wiley Online Library
Objective Postoperative radioiodine remnant ablation (RRA) represents an adjunctive
therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late …
therapeutic modality in patients with differentiated thyroid cancer (DTC). The impact of late …
Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancer
SM El-Refaei, SW Yassin, K Salman… - Nuclear Medicine …, 2015 - journals.lww.com
Aim The aim of this study was to assess ablation outcome after a second ablation dose and
compare the ablation rate after low and high reablation doses of iodine-131 (131 I) after …
compare the ablation rate after low and high reablation doses of iodine-131 (131 I) after …
[PDF][PDF] Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal
WJG Oyen, C Verhagen, E Saris… - Journal of Nuclear …, 2000 - Soc Nuclear Med
For differentiated, nonmedullarythyroid carcinoma, postsurgical ablationof thyroid
remnantsand treatmentof residualtumor and metastaseswith 1311is a …
remnantsand treatmentof residualtumor and metastaseswith 1311is a …
Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan
M Chao - Clinical Oncology, 2010 - Elsevier
BACKGROUND: Differentiated thyroid carcinoma (DTC) with rising thyroglobulin (Tg) level
and negative radioiodine whole body scan results has been observed in follow-up studies …
and negative radioiodine whole body scan results has been observed in follow-up studies …
[HTML][HTML] Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an …
Currently a trend towards Bde-escalating^ the role of adjuvant iodine-131 (131I) in the
treatment of differentiated thyroid cancer can be observed in the community of clinical …
treatment of differentiated thyroid cancer can be observed in the community of clinical …
[HTML][HTML] Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - erc.bioscientifica.com
131 I is given in differentiated thyroid cancer (DTC) without taking into account thyroglobulin
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131I ablation therapy in patients with …
M Toubeau, C Touzery, P Arveux… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The aim of our study was to evaluate and compare in thyroid cancer patients the predictive
value for disease progression of thyroglobulin (Tg) levels measured under thyroid …
value for disease progression of thyroglobulin (Tg) levels measured under thyroid …